Nocturnal CPAP improves walking capacity in COPD patients with obstructive sleep apnoea

Tsai Yu Wang, Yu Lun Lo, Kang Yun Lee, Wen Te Liu, Shu Min Lin, Ting Yu Lin, Yung Lun Ni, Chao Yung Wang, Shu Chuan Ho, Han Pin Kuo

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Background: Exercise limitation is an important issue in patients with chronic obstructive pulmonary disease (COPD), and it often co-exists with obstructive sleep apnoea (overlap syndrome). This study examined the effects of nocturnal continuous positive airway pressure (CPAP) treatment on walking capacity in COPD patients with or without obstructive sleep apnoea.Methods: Forty-four stable moderate-to-severe COPD patients were recruited and completed this study. They all underwent polysomnography, CPAP titration, accommodation, and treatment with adequate pressure. The incremental shuttle walking test was used to measure walking capacity at baseline and after two nights of CPAP treatment. Urinary catecholamine and heart rate variability were measured before and after CPAP treatment.Results: After two nights of CPAP treatment, the apnoea-hypopnoea index and oxygen desaturation index significantly improved in both overlap syndrome and COPD patients, however these changes were significantly greater in the overlap syndrome than in the COPD group. Sleep architecture and autonomic dysfunction significantly improved in the overlap syndrome group but not in the COPD group. CPAP treatment was associated with an increased walking capacity from baseline from 226.4 ± 95.3 m to 288.6 ± 94.6 m (P <0.05), and decreased urinary catecholamine levels, pre-exercise heart rate, oxygenation, and Borg scale in the overlap syndrome group. An improvement in the apnoea-hypopnoea index was an independent factor associated with the increase in walking distance (r = 0.564).Conclusion: Nocturnal CPAP may improve walking capacity in COPD patients with overlap syndrome.Trial registration: NCT00914264.

Original languageEnglish
Article number66
JournalRespiratory Research
Volume14
Issue number1
DOIs
Publication statusPublished - Jun 19 2013
Externally publishedYes

Fingerprint

Continuous Positive Airway Pressure
Obstructive Sleep Apnea
Chronic Obstructive Pulmonary Disease
Walking
Apnea
Catecholamines
Therapeutics
Heart Rate
Exercise
Polysomnography
Sleep
Oxygen
Pressure

Keywords

  • Autonomic dysfunction
  • Chronic obstructive pulmonary disease
  • Continuous positive airway pressure
  • Obstructive sleep apnoea
  • Walking capacity

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Medicine(all)

Cite this

Nocturnal CPAP improves walking capacity in COPD patients with obstructive sleep apnoea. / Wang, Tsai Yu; Lo, Yu Lun; Lee, Kang Yun; Liu, Wen Te; Lin, Shu Min; Lin, Ting Yu; Ni, Yung Lun; Wang, Chao Yung; Ho, Shu Chuan; Kuo, Han Pin.

In: Respiratory Research, Vol. 14, No. 1, 66, 19.06.2013.

Research output: Contribution to journalArticle

Wang, Tsai Yu ; Lo, Yu Lun ; Lee, Kang Yun ; Liu, Wen Te ; Lin, Shu Min ; Lin, Ting Yu ; Ni, Yung Lun ; Wang, Chao Yung ; Ho, Shu Chuan ; Kuo, Han Pin. / Nocturnal CPAP improves walking capacity in COPD patients with obstructive sleep apnoea. In: Respiratory Research. 2013 ; Vol. 14, No. 1.
@article{7dd8f91bac4d4934a068a93627a42c81,
title = "Nocturnal CPAP improves walking capacity in COPD patients with obstructive sleep apnoea",
abstract = "Background: Exercise limitation is an important issue in patients with chronic obstructive pulmonary disease (COPD), and it often co-exists with obstructive sleep apnoea (overlap syndrome). This study examined the effects of nocturnal continuous positive airway pressure (CPAP) treatment on walking capacity in COPD patients with or without obstructive sleep apnoea.Methods: Forty-four stable moderate-to-severe COPD patients were recruited and completed this study. They all underwent polysomnography, CPAP titration, accommodation, and treatment with adequate pressure. The incremental shuttle walking test was used to measure walking capacity at baseline and after two nights of CPAP treatment. Urinary catecholamine and heart rate variability were measured before and after CPAP treatment.Results: After two nights of CPAP treatment, the apnoea-hypopnoea index and oxygen desaturation index significantly improved in both overlap syndrome and COPD patients, however these changes were significantly greater in the overlap syndrome than in the COPD group. Sleep architecture and autonomic dysfunction significantly improved in the overlap syndrome group but not in the COPD group. CPAP treatment was associated with an increased walking capacity from baseline from 226.4 ± 95.3 m to 288.6 ± 94.6 m (P <0.05), and decreased urinary catecholamine levels, pre-exercise heart rate, oxygenation, and Borg scale in the overlap syndrome group. An improvement in the apnoea-hypopnoea index was an independent factor associated with the increase in walking distance (r = 0.564).Conclusion: Nocturnal CPAP may improve walking capacity in COPD patients with overlap syndrome.Trial registration: NCT00914264.",
keywords = "Autonomic dysfunction, Chronic obstructive pulmonary disease, Continuous positive airway pressure, Obstructive sleep apnoea, Walking capacity",
author = "Wang, {Tsai Yu} and Lo, {Yu Lun} and Lee, {Kang Yun} and Liu, {Wen Te} and Lin, {Shu Min} and Lin, {Ting Yu} and Ni, {Yung Lun} and Wang, {Chao Yung} and Ho, {Shu Chuan} and Kuo, {Han Pin}",
year = "2013",
month = "6",
day = "19",
doi = "10.1186/1465-9921-14-66",
language = "English",
volume = "14",
journal = "Respiratory Research",
issn = "1465-9921",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Nocturnal CPAP improves walking capacity in COPD patients with obstructive sleep apnoea

AU - Wang, Tsai Yu

AU - Lo, Yu Lun

AU - Lee, Kang Yun

AU - Liu, Wen Te

AU - Lin, Shu Min

AU - Lin, Ting Yu

AU - Ni, Yung Lun

AU - Wang, Chao Yung

AU - Ho, Shu Chuan

AU - Kuo, Han Pin

PY - 2013/6/19

Y1 - 2013/6/19

N2 - Background: Exercise limitation is an important issue in patients with chronic obstructive pulmonary disease (COPD), and it often co-exists with obstructive sleep apnoea (overlap syndrome). This study examined the effects of nocturnal continuous positive airway pressure (CPAP) treatment on walking capacity in COPD patients with or without obstructive sleep apnoea.Methods: Forty-four stable moderate-to-severe COPD patients were recruited and completed this study. They all underwent polysomnography, CPAP titration, accommodation, and treatment with adequate pressure. The incremental shuttle walking test was used to measure walking capacity at baseline and after two nights of CPAP treatment. Urinary catecholamine and heart rate variability were measured before and after CPAP treatment.Results: After two nights of CPAP treatment, the apnoea-hypopnoea index and oxygen desaturation index significantly improved in both overlap syndrome and COPD patients, however these changes were significantly greater in the overlap syndrome than in the COPD group. Sleep architecture and autonomic dysfunction significantly improved in the overlap syndrome group but not in the COPD group. CPAP treatment was associated with an increased walking capacity from baseline from 226.4 ± 95.3 m to 288.6 ± 94.6 m (P <0.05), and decreased urinary catecholamine levels, pre-exercise heart rate, oxygenation, and Borg scale in the overlap syndrome group. An improvement in the apnoea-hypopnoea index was an independent factor associated with the increase in walking distance (r = 0.564).Conclusion: Nocturnal CPAP may improve walking capacity in COPD patients with overlap syndrome.Trial registration: NCT00914264.

AB - Background: Exercise limitation is an important issue in patients with chronic obstructive pulmonary disease (COPD), and it often co-exists with obstructive sleep apnoea (overlap syndrome). This study examined the effects of nocturnal continuous positive airway pressure (CPAP) treatment on walking capacity in COPD patients with or without obstructive sleep apnoea.Methods: Forty-four stable moderate-to-severe COPD patients were recruited and completed this study. They all underwent polysomnography, CPAP titration, accommodation, and treatment with adequate pressure. The incremental shuttle walking test was used to measure walking capacity at baseline and after two nights of CPAP treatment. Urinary catecholamine and heart rate variability were measured before and after CPAP treatment.Results: After two nights of CPAP treatment, the apnoea-hypopnoea index and oxygen desaturation index significantly improved in both overlap syndrome and COPD patients, however these changes were significantly greater in the overlap syndrome than in the COPD group. Sleep architecture and autonomic dysfunction significantly improved in the overlap syndrome group but not in the COPD group. CPAP treatment was associated with an increased walking capacity from baseline from 226.4 ± 95.3 m to 288.6 ± 94.6 m (P <0.05), and decreased urinary catecholamine levels, pre-exercise heart rate, oxygenation, and Borg scale in the overlap syndrome group. An improvement in the apnoea-hypopnoea index was an independent factor associated with the increase in walking distance (r = 0.564).Conclusion: Nocturnal CPAP may improve walking capacity in COPD patients with overlap syndrome.Trial registration: NCT00914264.

KW - Autonomic dysfunction

KW - Chronic obstructive pulmonary disease

KW - Continuous positive airway pressure

KW - Obstructive sleep apnoea

KW - Walking capacity

UR - http://www.scopus.com/inward/record.url?scp=84879035780&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879035780&partnerID=8YFLogxK

U2 - 10.1186/1465-9921-14-66

DO - 10.1186/1465-9921-14-66

M3 - Article

C2 - 23782492

AN - SCOPUS:84879035780

VL - 14

JO - Respiratory Research

JF - Respiratory Research

SN - 1465-9921

IS - 1

M1 - 66

ER -